Trump says envoy Witkoff had productive meeting with Putin
On Monday, Immatics N.V. (NASDAQ:IMTX), a company based in Tübingen, Germany, announced the scheduling of its annual general meeting. According to a filing with the Securities and Exchange Commission, the meeting is set for June 18, 2025, at 4:00 PM CEST. It will be held at the offices of NautaDutilh N.V. in Amsterdam, Netherlands.
The company has made available to its shareholders a convening notice, which outlines the details of the meeting. The agenda and other related documents, including a proxy card and the form of the 2025 Immatics Stock Option & Incentive Plan, are also accessible to shareholders.
Immatics N.V. operates in the biological products sector, focusing on innovative cancer immunotherapies. The company, previously known as Immatics B.V., changed its name in April 2020. The filing, submitted under Form 6-K, is part of the company’s compliance with the Securities Exchange Act of 1934.
This information is based on a press release statement filed with the SEC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.